Holger Weis
Chairman bei ALAUNOS THERAPEUTICS, INC.
Vermögen: 21 914 $ am 31.03.2024
Aktive Positionen von Holger Weis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Chairman | 22.09.2023 | - |
Director/Board Member | 16.12.2020 | 22.09.2023 | |
Independent Dir/Board Member | 16.12.2020 | 22.09.2023 | |
JUPITER NEUROSCIENCES, INC. | Director/Board Member | 08.09.2021 | - |
Independent Dir/Board Member | 08.09.2021 | - |
Karriereverlauf von Holger Weis
Ehemalige bekannte Positionen von Holger Weis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Chief Operating Officer | 01.12.2011 | 24.07.2017 |
Director of Finance/CFO | 01.12.2011 | 24.07.2017 | |
President | 01.12.2011 | 24.07.2017 | |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | Director of Finance/CFO | 01.01.2006 | 01.08.2010 |
Corporate Secretary | 01.01.2006 | 01.08.2010 | |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Director of Finance/CFO | 01.01.2000 | 01.01.2005 |
Treasurer | 01.01.2000 | 01.01.2005 | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1986 | 01.01.2000 |
Ausbildung von Holger Weis
University of Georgia | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Griechenland | 2 |
Operativ
Director of Finance/CFO | 5 |
Director/Board Member | 3 |
President | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALAUNOS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | Health Services |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Health Technology |
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
- Börse
- Insiders
- Holger Weis
- Erfahrung